1PINMDEL D, WOOS. Prevention and treatment of meningeal leukemia in children [J]. Blood, 1994,84 : 355-360.
2KNOWLES D M. Neoplastichematopa[M]. Thologyzand ed New York : Lippincott Williams Wilkins ,2001 : 1643-1659.
3REITERF A, SCHRAPPE M, LUDWIG W D, et al. Chemotherapy in 1998 unselected childhood acute lymphoblastic leukemia patients. Resalts and condusions of the multicenter trial AIIBFM 86[J]. Blood,1994,84:3122-3129.
4PRIC H, CRIST W M. Biolgy and treatment of acute lymphobiastic leukemia[J]. J Pediatr, 1994,124 : 491-496.
5NESBIT M E. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukemia: Comparison of 1800 rad and 2400 rad[J]. Lancet, 1981,1 : 461- 467.
6PINDEL D, WOO, S. Prevention and treatment of meningeal leukemia in children[J]. Blood, 1994,84 : 355-361.
7KOMP D M CNS. Prophylaxis in acute lymphoblastic leukemia [J]. Cancer, 1982,50:1031-1038.
8CONTER V, ARICO M, VATSCCCHL M G, et al. Extended intranthecal methotrexate may replace cranial irradiation for prevention of CNS relapse in Children with intermediaterisd acute lymphoblastic leukemia reared ith Berin-Frankfurt-Munster-Basedintensive Chemotherapy [J ]. J Clin Oncol, 1995, 13 : 2497- 2501.
9PEARSON A D J, AMINED DINE H A, YULE M, et al. The influence of serum methotrexate concentration and drug dosage on outcome in childhood acute lymphoblasticleukemia [J]. Br J Cancer, 1994,64:169-174.
10SYNOLE T W, RELLING M V, BOYETT J M, et al. Blastcell methotrexate-polyglutamate accumulation in vivo differs by linease, ploidy, and methotrexate dose in acute lymphoblast leukemia[J]. J Clin Invest,1994,94:1996-1999.
